ロード中...
MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
Glioma is a brain tumour that is often diagnosed, and temozolomide (TMZ) is a common chemotherapeutic drug used in glioma. Yet, resistance to TMZ is a chief hurdle towards curing the malignancy. The current work explores the pathways and involvement of miR‐3116 in the TMZ resistance. miR‐3116 and FG...
保存先:
| 出版年: | J Cell Mol Med |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7176860/ https://ncbi.nlm.nih.gov/pubmed/32181582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15133 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|